Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Fizesan, M., Boin, C., Aujoulat, O., Newinger, G., Ghergus, D., Watier, H., Lustig, H., Ojeda-Uribe, M. Tags: Letter to the Editor Source Type: research
More News: Cancer & Oncology | Lymphoma